AMI-605

N/A

Report date: 2024/05/13 10:59:25
NME

Base Information

Drug NameAMI-605
Drug Alias NameAMI605AMI-605
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcipressin-1 inhibitors
TargetsCalcipressin-1
Therapy Area/IndicationsCentral Nervous System NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmira Therapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesAmira Therapeutics SL
Inactive CompaniesN/A
Active IndicationsCentral Nervous System NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A